My da|ra Login

Detailed view

metadata language: English

Replication data for: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India

Version
1
Resource Type
Dataset
Creator
  • Duggan, Mark
  • Garthwaite, Craig
  • Goyal, Aparajita
Publication Date
2016-01-01
Description
  • Abstract

    In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent, with larger increases for more recently developed molecules and for those produced by just one firm when the patent system began. Our results also show little impact on quantities sold or on the number of pharmaceutical firms operating in the market. (JEL K33, L11, L13, L65, O14, O34, O38)
Availability
Download
Relations
  • Is supplement to
    DOI: 10.1257/aer.20141301 (Text)
Publications
  • Duggan, Mark, Craig Garthwaite, and Aparajita Goyal. “The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India.” American Economic Review 106, no. 1 (January 2016): 99–135. https://doi.org/10.1257/aer.20141301.
    • ID: 10.1257/aer.20141301 (DOI)

Update Metadata: 2020-02-07 | Issue Number: 1 | Registration Date: 2020-02-07

Duggan, Mark; Garthwaite, Craig; Goyal, Aparajita (2016): Replication data for: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India. Version: 1. ICPSR - Interuniversity Consortium for Political and Social Research. Dataset. https://doi.org/10.3886/E113010V1-22203